Federal regulators approved the first 3D-printed drug, a groundbreaking decision that could change how drugs are made.
The Food and Drug Administration approved the anti-seizure drug Spritam on Monday, according to the drug’s manufacturer, Aprecia Pharmaceuticals.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
Already a member? Log in
Spritam is made through a 3D printing technique that produces a porous formulation that “rapidly disintegrates with a sip of liquid,” the company said.
The technique could be helpful for children and seniors who may have trouble taking traditional medication, said Dr. Marvin Rorick, a Cincinnati neurologist.
“In my experience, patients and caregivers often have difficulty following a treatment regimen,” he said. “Whether they are dealing with a swallowing disorder or the daily struggle of getting a child to take his or her medication, adherence can be a challenge.”
The FDA has previously approved medical devices created through the technology, but never a drug.
Aprecia holds a license for pharmaceutical applications with the 3D technique.
